272 related articles for article (PubMed ID: 8161313)
21. Treatment of hypertension in chronic kidney disease.
Toto RD
Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
[TBL] [Abstract][Full Text] [Related]
22. [New goals in hypertension management: target-organ protection beyond blood pressure lowering].
Safar ME; Struijker-Boudier HA
Drugs; 2003; 63 Spec No 1():45-7. PubMed ID: 12708882
[TBL] [Abstract][Full Text] [Related]
23. Risk factors and differential antihypertensive therapies.
Os I
Acta Med Austriaca; 1995; 22(3):45-7. PubMed ID: 8571750
[TBL] [Abstract][Full Text] [Related]
24. Long-term safety of antihypertensive therapy.
Grossman E; Messerli FH
Prog Cardiovasc Dis; 2006; 49(1):16-25. PubMed ID: 16867847
[TBL] [Abstract][Full Text] [Related]
25. Critical overview of antihypertensive therapies: what is preventing us from getting there? Based on a presentation by Mark A. Munger, PharmD.
Am J Manag Care; 2000 Mar; 6(4 Suppl):S211-21. PubMed ID: 10977461
[TBL] [Abstract][Full Text] [Related]
26. Actual blood pressure control: are we doing things right?
Coca A
J Hypertens Suppl; 1998 Jan; 16(1):S45-51. PubMed ID: 9534097
[TBL] [Abstract][Full Text] [Related]
27. [Predictors of cardiovascular mortality and morbidity in hypertension].
Laurent S
Curr Med Res Opin; 2005; 21 Suppl 5():S7-11. PubMed ID: 16197646
[TBL] [Abstract][Full Text] [Related]
28. Impact of treating hyperlipidemia or hypertension to reduce the risk of death from coronary artery disease.
Perreault S; Dorais M; Coupal L; Paradis G; Joffres MR; Grover SA
CMAJ; 1999 May; 160(10):1449-55. PubMed ID: 10352634
[TBL] [Abstract][Full Text] [Related]
29. [Coronary artery disease].
Watanabe Y; Daida H
Nihon Rinsho; 2003 Jul; 61(7):1181-6. PubMed ID: 12877082
[TBL] [Abstract][Full Text] [Related]
30. [Heart, brain and hypertension].
Lüscher TF; Sturzenegger M; Noll G
Schweiz Med Wochenschr; 1996 Aug; 126(34):1449-56. PubMed ID: 8848709
[TBL] [Abstract][Full Text] [Related]
31. Hypertension and its management: a problem in need of new treatment strategies.
Neutel JM
J Renin Angiotensin Aldosterone Syst; 2000 Jun; 1(2 Suppl):S10-3. PubMed ID: 17199212
[TBL] [Abstract][Full Text] [Related]
32. [Cardiovascular risk in hemodialysis in Spain: prevalence, management and target results (MAR study)].
Portolés J; López-Gómez JM; Aljama P
Nefrologia; 2005; 25(3):297-306. PubMed ID: 16053011
[TBL] [Abstract][Full Text] [Related]
33. [Prevention trials and role of vascular factors in moderate arterial hypertension].
Safar M
Arch Mal Coeur Vaiss; 1987 Apr; 80 Spec No():23-7. PubMed ID: 3113394
[TBL] [Abstract][Full Text] [Related]
34. Hypertension and coronary artery disease in the elderly.
Messerli FH; Grodzicki T
Clin Geriatr Med; 1996 Feb; 12(1):41-56. PubMed ID: 8653662
[TBL] [Abstract][Full Text] [Related]
35. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
[TBL] [Abstract][Full Text] [Related]
36. [Modern antihypertensive drug therapy].
Spieker C; Barenbrock M; Rahn KH
Fortschr Med; 1996 Nov; 114(32):425-30. PubMed ID: 9064265
[TBL] [Abstract][Full Text] [Related]
37. Uric acid in hypertension and cardiovascular disease.
Alderman M
Can J Cardiol; 1999 Nov; 15 Suppl F():20F-2F. PubMed ID: 10579748
[TBL] [Abstract][Full Text] [Related]
38. Elevated systolic blood pressure as a risk factor for cardiovascular and renal disease.
He J; Whelton PK
J Hypertens Suppl; 1999 Jun; 17(2):S7-13. PubMed ID: 10465061
[TBL] [Abstract][Full Text] [Related]
39. Metabolic and cardiovascular characteristics of hypertension. Familial aspects.
Neutel JM; Smith DH
Cardiol Clin; 1995 Nov; 13(4):539-47. PubMed ID: 8565017
[TBL] [Abstract][Full Text] [Related]
40. [Hypertension and hyperlipidemia].
Hansen HS; Larsen ML
Ugeskr Laeger; 2009 Jun; 171(24):2028-30. PubMed ID: 19523369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
